A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

Clinical trial NCT03960814 · COMPLETED

Trial details

NCT number: NCT03960814
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2019-05-21
Primary completion: 2019-06-07
Enrollment: 12847

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.